Amoxicillin NDC 68999-825

NDC codes

FDA NDC Directory

Product NDC (as listed)68999-825Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68999-0825Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68999-825-01	68999082501	100 CAPSULE in 1 BOTTLE (68999-825-01)Marketed from Jun 24, 2022
68999-825-60	68999082560	60 CAPSULE in 1 BOTTLE (68999-825-60)Marketed from Jun 24, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Amoxicillin
Generic name (nonproprietary): amoxicillin
Active ingredients: Amoxicillin — 500 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Chartwell Governmental & Specialty RX, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 062058
Marketing start: Aug 3, 1978
Listing expires: Dec 31, 2026
Other FDA classes: Penicillins (Chemical structure)
Identifiers: Product ID 68999-825_46911108-ba5e-8cba-e063-6294a90adcccSPL ID 46911108-ba5e-8cba-e063-6294a90adcccSPL set ID f9062321-ffb3-42e8-8f98-453cd30f5282RxCUI 308182, 308191UNII 804826J2HUUPC 0368999824015, 0368999825609, 0368999825012
Pharmacologic class: Penicillin-class Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468999082501 followed by a unit qualifier and the quantity

Package 68999-0825-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 22, 2025.

Indications (excerpt from the label)

Adults and Pediatric Patients Upper Respiratory Tract Infections of the Ear, Nose, and Throat: Amoxicillin capsules are indicated in the treatment of infections due to susceptible (ONLY β-lactamase-negative) isolates of Streptococcus species. (α- and β-hemolytic isolates only), Streptococcus pneumoniae , Staphylococcus spp., or Haemophilus influenzae . Infections of the Genitourinary Tract: Amoxicillin capsules are indicated in the treatment of infections due to susceptible (ONLY β-lactamase-negative) isolates of Escherichia coli , Proteus mirabilis , or Enterococcus faecalis . Infections of the Skin and Skin Structure: Amoxicillin capsules are indicated in the treatment of infections due to…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 062058

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 062058
Product	Strength	Form · route	Labeler	Product NDC
Amoxicillin	Amoxicillin 250 mg/1	CapsuleOral	Chartwell Governmental & Specialty RX, LLC	68999-824
Amoxicillin	Amoxicillin 500 mg/1	CapsuleOral	Chartwell RX, LLC	62135-825
Amoxicillin	Amoxicillin 250 mg/1	CapsuleOral	Chartwell RX, LLC	62135-824